COVAXIN COVID 19 VACCINE
Covaxin Approved in Oman; Vaccinated Indian Nationals Can Travel to The Country Without Quarantine
Covaxin COVID-19 Vaccine Shows 77.8% Overall Efficacy, 65.2% Protection Against Delta Variant, Claims Bharat Biotech in Results From Phase 3 Clinical Trials
COVAXIN Phase 2 and 3 Trials for 2 to 18 Age Group Approved by DCGI, Bharat Biotech To Conduct Trials on 525 Healthy Volunteers
Covaxin, Bharat Biotech’s COVID-19 Vaccine, Has Been Approved for Children Above 12 Years? PIB Fact Check Reveals Truth Behind Fake Tweet
Covaxin Fact Sheet: Bharat Biotech Releases Advisory Warning People With Medical Conditions, Pregnant Women To Avoid Vaccine Shot, Check Full Advisory Here
Google Trends